Rao Satish S C
Division of Gastroenterology & Hepatology, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
Gastroenterol Clin North Am. 2007 Sep;36(3):687-711, x. doi: 10.1016/j.gtc.2007.07.013.
This article focuses on the colonic and anorectal motility disturbances that are associated with chronic constipation and their management. Functional chronic constipation consists of three overlapping subtypes: slow transit constipation, dyssynergic defecation, and irritable bowel syndrome with constipation. The Rome criteria may serve as a useful guide for making a clinical diagnosis of functional constipation. Today, an evidence-based approach can be used to treat patients with chronic constipation. The availability of specific drugs for the treatment of chronic constipation, such as tegaserod and lubiprostone, has enhanced the therapeutic armamentarium for managing these patients. Randomized controlled trials have also established the efficacy of biofeedback therapy in the treatment of dyssynergic defecation.
本文重点关注与慢性便秘相关的结肠和肛肠动力障碍及其管理。功能性慢性便秘由三种重叠的亚型组成:慢传输型便秘、排便协同失调和便秘型肠易激综合征。罗马标准可作为功能性便秘临床诊断的有用指南。如今,可采用循证医学方法治疗慢性便秘患者。治疗慢性便秘的特效药物(如替加色罗和鲁比前列酮)的出现,增强了治疗这些患者的手段。随机对照试验也证实了生物反馈疗法在治疗排便协同失调方面的疗效。